Comments
*
Login
Register
Home
My ASBMR
|
My Community
|
Member Directory
About Us
Overview
Leadership
Committees
President's Corner
News Releases
Partnerships
Policies and Procedures
Related Links
Contact
Staff
Meetings
Annual Meeting
Topical Meetings
Past Annual Meetings
Future Annual Meetings
ASBMR Awards
Events Calendar
Publications
JBMR
Primer
ASBMR eNews
In the Field
Contact
Grants
Funding Opportunities
Resources
Grant Writing Tips
Career Center
Job Board
Mentor Program
Career Advice
Education
Bone Curriculum
Webinars
Primer Slide Sets
Educational Resources
Advocacy
Advocacy Resources
Initiatives
National Action Plan
Membership
Join ASBMR
Member Directory
Renew Membership
Donate to ASBMR
Volunteer Nomination Form
ASBMR Videos
Give Us Your Feedback
ASBMR Mourns the Passing of Dr. Greg Mundy
Share Your Fond Memories
Call for Volunteer Nominations
Deadline: Wednesday, March 17, 2010
Abstract Center Now Open
Submit your abstract for the ASBMR 2010 Annual Meeting
Bisphosphonate Therapy and Atypical Fractures
Guidance for Osteoporosis Patients and Healthcare Professionals
Headlines
The Journal of Bone and Mineral Research
February 2010
Volume 25
Issue 2
Visit
JBMR Online
Editor's Choice
Thomas L. Clemens, Ph.D.
Editor-in-Chief
Commentary:
Building bone with a
SOST
-PTH partnership
Original Article:
Bone mass and strength in older men with type 2 diabetes: The Osteoporotic Fractures in Men Study
Original Article:
Obesity and fractures in postmenopausal women
Read More
In the Field
Open Discussion & Viewpoints Around the Current Literature
Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes
Bone. 2010 Feb 23
Commentary
Discuss This
Lasofoxifene in postmenopausal women with osteoporosis
N Engl J Med. 2010 Feb 25;362(8):686-96
Commentary
Discuss This
FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts
Cell Metab. 2010 Feb 3;11(2):147-60.
Commentary
Discuss This
Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk
Br J Cancer. 2010 Mar 2;102(5):799-802. Epub 2010 Feb 16.
Commentary
Discuss This
Popular Discussions
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Last Comment by: Dr. Abdulhafez Abdulwahed Selim 9/14/2009 in: In the Field Discussions
Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum
Last Comment by: 9/2/2009 in: Ask the Author
TGF-1–Induced Migration of Bone Mesenchymal Stem Cells Couples Bone Resorption with Formation
Last Comment by: 8/12/2009 in: In the Field Discussions
ASBMR News Feed
Events
April 6 - 10, 2010
AIMM John Haddad Young Investigators' Meeting
May 5 - 8, 2010
World Congress on Osteoporosis
May 18 - 21, 2010
1st Latin American Symposium on the Molecular Mechanisms of Skeletal Mineralization
Email a Friend
Your Name
Your Email
Recipient's Email
Your Comments